In addition, the study by Wang and co-authors (2018) shows that conditional deletion of HDAC8 in Foxp3+ Treg cells or the use of HDAC8 inhibitors impairs Treg function and promotes anti-tumor immunity (251). The gene discussed is HDAC8; the disease is neoplasm.